Search Browse Earnings

Tracon Pharmaceuticals, Inc.

Biological Products, (No Diagnostic Substances)·San Diego, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$346,000

FY 2023

Adj. EBITDA

-$28.3M

-8188.7% margin

FY 2023

Net Income

-$28.7M

-8285.3% margin

FY 2023

EPS (Diluted)

-$1.66

FY 2023

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$17.4M

FY 2023

Total Debt

$12.5M

FY 2021

Net Cash

$4.9M

FY 2021

Enterprise Value

—

Debt / EBITDA

0.2x

FY 2023

EV / EBITDA

—

Employees

—

CEO

Theuer Charles